These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3768285)

  • 21. [Gestosis index and perinatal mortality].
    Jürgens H; Dichmann R
    Zentralbl Gynakol; 1975; 97(19):1201-11. PubMed ID: 1189794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia.
    Buyon JP; Cronstein BN; Morris M; Tanner M; Weissmann G
    Am J Med; 1986 Aug; 81(2):194-200. PubMed ID: 3740078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.
    Thornton CE; Makris A; Ogle RF; Tooher JM; Hennessy A
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):466-70. PubMed ID: 19930427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of oxidative DNA damage, protein oxidation and antioxidant function with oxidative stress induced cellular injury in pre-eclamptic/eclamptic mothers during fetal circulation.
    Negi R; Pande D; Karki K; Kumar A; Khanna RS; Khanna HD
    Chem Biol Interact; 2014 Feb; 208():77-83. PubMed ID: 24296128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women.
    Kaiser T; Brennecke SP; Moses EK
    Gynecol Obstet Invest; 2000; 50(2):100-2. PubMed ID: 10965192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension.
    Homer CS; Brown MA; Mangos G; Davis GK
    J Hypertens; 2008 Feb; 26(2):295-302. PubMed ID: 18192844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA antigens in severe pre-eclampsia.
    Redman CW; Bodmer JG; Bodmer WF; Beilin LJ; Bonnar J
    Lancet; 1978 Aug; 2(8086):397-9. PubMed ID: 79762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prothrombin G20210A mutation: is it associated with pre-eclampsia?
    Higgins JR; Kaiser T; Moses EK; North R; Brennecke SP
    Gynecol Obstet Invest; 2000; 50(4):254-7. PubMed ID: 11093048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The -56T HLA-G promoter polymorphism is not associated with pre-eclampsia/eclampsia in Australian and New Zealand women.
    Doherty VL; Rush AN; Brennecke SP; Moses EK
    Hypertens Pregnancy; 2006; 25(2):63-71. PubMed ID: 16867913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and microalbuminuria 5 years after pregnancies complicated by pre-eclampsia.
    Shahbazian N; Shahbazian H; Ehsanpour A; Aref A; Gharibzadeh S
    Iran J Kidney Dis; 2011 Sep; 5(5):324-7. PubMed ID: 21876309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunologic concept of EPH-gestosis.
    Gleicher N; Siegel I
    Prog Clin Biol Res; 1981; 70():229-43. PubMed ID: 7031692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction.
    Sziller I; Babula O; Hupuczi P; Nagy B; Rigó B; Szabó G; Papp Z; Linhares IM; Witkin SS
    Mol Hum Reprod; 2007 Apr; 13(4):281-5. PubMed ID: 17314117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine gene polymorphisms in preeclampsia and eclampsia.
    de Lima TH; Sass N; Mattar R; Moron AF; Torloni MR; Franchim CS; Daher S
    Hypertens Res; 2009 Jul; 32(7):565-9. PubMed ID: 19407822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia.
    Herrera JA; Parra B; Herrera E; Botero JE; Arce RM; Contreras A; López-Jaramillo P
    J Hypertens; 2007 Jul; 25(7):1459-64. PubMed ID: 17563569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic control of severe pre-eclampsia.
    Cooper DW; Liston WA
    J Med Genet; 1979 Dec; 16(6):409-16. PubMed ID: 537013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New insights into the etiology and pathogenesis of pre-eclampsia].
    Hviid UR; Hviid TV
    Ugeskr Laeger; 2000 Nov; 162(45):6057-61. PubMed ID: 11107941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypertension in pregnancy].
    Delmis J
    Lijec Vjesn; 2006; 128(11-12):357-68. PubMed ID: 17212198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cerebral magnetic resonance and electroencephalogram findings in pre-eclamptic and eclamptic women.
    Osmanağaoğlu MA; Dinç G; Osmanağaoğlu S; Dinç H; Bozkaya H
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):384-90. PubMed ID: 16171473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3 allotypes in pregnancy hypertension and eclampsia.
    Cooper DW; Deane EM; Marshall P; Gallery ED
    Hum Hered; 1988; 38(1):52-5. PubMed ID: 3350532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental Proteomics Provides Insights into Pathophysiology of Pre-Eclampsia and Predicts Possible Markers in Plasma.
    Mary S; Kulkarni MJ; Malakar D; Joshi SR; Mehendale SS; Giri AP
    J Proteome Res; 2017 Feb; 16(2):1050-1060. PubMed ID: 28030762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.